0000899243-22-007494.txt : 20220223 0000899243-22-007494.hdr.sgml : 20220223 20220223194220 ACCESSION NUMBER: 0000899243-22-007494 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220220 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barclay Alec CENTRAL INDEX KEY: 0001734339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 22665812 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-20 0 0001492674 T2 Biosystems, Inc. TTOO 0001734339 Barclay Alec 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Operations Officer Common Stock 2021-02-21 4 M 0 10000 A 84420 D Common Stock 2021-02-21 4 F 0 5275 0.466 D 79145 D Restricted Stock Units 2022-02-20 4 A 0 600000 0.00 A Common Stock 600000 600000 D Restricted Stock Units 2022-02-21 4 M 0 10000 0.00 D Common Stock 10000 0 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. 5,275 shares of common stock were automatically withheld at vesting to cover required tax withholding. On February 20, 2022 the reporting person was granted 600,000 RSU's that vest in three equal annual installments commencing on February 20, 2022. On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments commencing on February 21, 2020.. /s/ John Sprague, Attorney-in-fact 2022-02-23